1. Home
  2. CLPT vs CCAP Comparison

CLPT vs CCAP Comparison

Compare CLPT & CCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearPoint Neuro Inc.

CLPT

ClearPoint Neuro Inc.

HOLD

Current Price

$10.74

Market Cap

494.6M

Sector

Health Care

ML Signal

HOLD

Logo Crescent Capital BDC Inc.

CCAP

Crescent Capital BDC Inc.

HOLD

Current Price

$12.75

Market Cap

492.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLPT
CCAP
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
494.6M
492.4M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
CLPT
CCAP
Price
$10.74
$12.75
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
$21.50
$16.33
AVG Volume (30 Days)
948.0K
177.4K
Earning Date
04-06-2026
01-01-0001
Dividend Yield
N/A
13.11%
EPS Growth
22.22
N/A
EPS
N/A
N/A
Revenue
$31,390,000.00
N/A
Revenue This Year
$18.93
N/A
Revenue Next Year
$51.64
N/A
P/E Ratio
N/A
$14.18
Revenue Growth
31.04
N/A
52 Week Low
$8.63
$12.56
52 Week High
$30.10
$17.97

Technical Indicators

Market Signals
Indicator
CLPT
CCAP
Relative Strength Index (RSI) 41.50 37.77
Support Level $10.57 $12.56
Resistance Level $11.69 $14.70
Average True Range (ATR) 1.01 0.42
MACD -0.02 -0.01
Stochastic Oscillator 31.38 23.04

Price Performance

Historical Comparison
CLPT
CCAP

About CLPT ClearPoint Neuro Inc.

ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.

About CCAP Crescent Capital BDC Inc.

Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.

Share on Social Networks: